Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age20+
SponsorKyoto University
About this trial
The purpose of this study is to evaluate the impact of perioperative aspirin continuation on clinical outcomes in patients with a history of coronary stent implantation who are scheduled for abdominal surgery.
Eligibility criteria
Qualifiers
Patients with a history of coronary stenting and scheduled for abdominal surgery
Patients on a single antiplatelet agent
Disqualifiers
Patients on dual antiplatelet therapy (DAPT)
Patients on anticoagulation therapy
Patients with a history of stent thrombosis
Patients with CHADS2 score >= 5
Trial design
Treatments tested in this trial
- Aspirin
- Aspirin interruption
Treatment groups
1,200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov